UTHR earnings: next report 2026-07-29, real EPS beat/miss history, analyst consensus Buy, P/E 18.01. Updated 2026-07-23.
United Therapeutics (UTHR) Research Hub
United Therapeutics (UTHR) trades on NASDAQ, US in the Healthcare (Biotechnology) sector. As of 2026-09-11, shares last closed at 497.11 USD (-1.92%), in a range — insufficient history for 200-DMA. Valuation: trailing P/E 18.01, market cap 22.38B. This hub links to the full technical, earnings and options research available for UTHR.
Last updated 2026-09-11 · Source: FMP end-of-day prices (adjusted); indicators computed by SniperIQ
| Sector | Healthcare (Biotechnology) |
|---|---|
| Exchange | NASDAQ, US |
| Last close | 497.11 USD (-1.92%) |
| 52-week range | 477.06 USD – 563.7 USD |
| Trend regime | Range |
| 14-day RSI | 35.8 (Bearish) |
| Trailing P/E | 18.01 |
| Market cap | 22.38B |
| Dividend yield | 0.00% |
| Next earnings | 2026-07-29 |
Available research for UTHR
Covered Call on UTHR: how it works, illustrative setup around the real 497.11 USD price, max profit/loss, breakeven and when to use it. Educational.
Iron Condor on UTHR: how it works, illustrative setup around the real 497.11 USD price, max profit/loss, breakeven and when to use it. Educational.
Protective Put on UTHR: how it works, illustrative setup around the real 497.11 USD price, max profit/loss, breakeven and when to use it. Educational.
UTHR technical analysis: range, last 497.11 USD, RSI 35.8, 52w range 477.06 USD–563.7 USD, real support/resistance. Updated 2026-09-11.
Frequently asked questions
What sector is UTHR in?
United Therapeutics (UTHR) is classified under Healthcare (Biotechnology), listed on NASDAQ, US.
Is UTHR in an uptrend or downtrend?
As of 2026-09-11, UTHR is in a range — insufficient history for 200-DMA. See the full technical research page for support and resistance levels.
What is UTHR's trailing P/E ratio?
UTHR's trailing P/E is 18.01, with a market cap of 22.38B. See the earnings research page for full valuation detail.
When does UTHR next report earnings?
UTHR is next scheduled to report earnings on 2026-07-29, with a consensus EPS estimate of 7.06 USD.